Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test

被引:73
|
作者
Warnecke, Tobias [1 ]
Suttrup, Inga [1 ]
Schroeder, Jens B. [1 ]
Osada, Nani [2 ]
Oelenberg, Stephan [1 ]
Hamacher, Christina [1 ]
Suntrup, Sonja [1 ]
Dziewas, Rainer [1 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Munster, Dept Med Informat, Domagkstr 9, D-48149 Munster, Germany
关键词
Parkinson's disease; Dysphagia; Swallowing; FEES; Levodopa responsiveness; DOPAMINERGIC STIMULATION; SWALLOWING ABNORMALITIES; AGREEMENT; DIAGNOSIS; THERAPY;
D O I
10.1016/j.parkreldis.2016.04.034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is still controversially discussed whether central dopaminergic stimulation improves swallowing ability in Parkinson's disease (PD). We evaluated the effect of oral levodopa application on dysphagia in advanced PD patients with motor fluctuations. Methods: In 15 PD patients (mean age 71.93 +/- 8.29 years, mean disease duration 14.33 +/- 5.94 years) with oropharyngeal dysphagia and motor fluctuations endoscopic swallowing evaluation was performed in the off state and on state condition following a specifically developed protocol (FEES-levodopa-test). The respective dysphagia score covered three salient parameters, i.e. premature spillage, penetration/aspiration events and residues, each tested with liquid as well as semisolid and solid food consistencies. An improvement of >30% in this score indicated levodopa responsiveness of dysphagia. Measures were compared between the off-and on-state condition by using the Wilcoxon Test and marginal homogeneity test. Inter- and intrarater reliability was also investigated. Results: Severity of swallowing dysfunction in the off state varied widely. The lowest dysphagia score was 15 points (dysphagia without any aspiration risk). The highest dysphagia score was 84 points (dysphagia with aspiration of all consistencies). Seven patients showed a marked improvement of dysphagia in the on state condition. Eight PD patients did not respond. Inter- and intrarater reliability was excellent for all three subscales in the off state and on state conditions. Conclusions: A significant proportion of advanced PD patients with motor fluctuations and mild to moderate oropharyngeal dysphagia may demonstrate a clinically relevant improvement of swallowing after levodopa challenge. The FEES-levodopa-test is a reliable and sensitive tool to differentiate these responders from non-responders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [31] Factitious disorder mimicking addiction to levodopa in a patient with advanced Parkinson's disease
    Teixeira-Jr, AL
    Cardoso, F
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (2A) : 324 - 326
  • [32] Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
    Tsunemi, Taiji
    Oyama, Genko
    Saiki, Shinji
    Hatano, Taku
    Fukae, Jiro
    Shimo, Yasushi
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2021, 36 (08) : 1759 - 1771
  • [33] Parkinson's disease, levodopa-use and the risk of melanoma
    Vermeij, J-D.
    Winogrodzka, A.
    Trip, J.
    Weber, W. E. J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (08) : 551 - 553
  • [34] Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's Disease
    Mueller, Karsten
    Jech, Robert
    Ballarini, Tommaso
    Holiga, Stefan
    Ruzicka, Filip
    Piecha, Fabian A.
    Moeller, Harald E.
    Vymazal, Josef
    Ruzicka, Evzen
    Schroeter, Matthias L.
    CEREBELLUM, 2019, 18 (02) : 212 - 224
  • [35] Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease
    Leta, Valentina
    Klingelhoefer, Lisa
    Longardner, Katherine
    Campagnolo, Marta
    Levent, Hafize Cotur
    Aureli, Federico
    Metta, Vinod
    Bhidayasiri, Roongroj
    Chung-Faye, Guy
    Falup-Pecurariu, Cristian
    Stocchi, Fabrizio
    Jenner, Peter
    Warnecke, Tobias
    Chaudhuri, K. Ray
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (05) : 1465 - 1480
  • [36] Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications
    Yang, Hui-Jun
    Ehm, Gwanhee
    Kim, Young Eun
    Yun, Ji Young
    Lee, Woong-Woo
    Kim, Aryun
    Kim, Han-Joon
    Jeon, Beomseok
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 : 6 - 11
  • [37] Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease
    Kevin J Black
    Tamara Hershey
    Johanna M Hartlein
    Juanita L Carl
    Joel S Perlmutter
    Neuropsychopharmacology, 2005, 30 : 590 - 601
  • [38] Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease
    Muhlack, S
    Woitalla, D
    Welnic, J
    Twiehaus, S
    Przuntek, H
    Müller, T
    NEUROSCIENCE LETTERS, 2004, 363 (03) : 284 - 287
  • [39] Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
    Antonini, Angelo
    Fung, Victor S. C.
    Boyd, James T.
    Slevin, John T.
    Hall, Coleen
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2016, 31 (04) : 530 - 537
  • [40] Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease
    Black, KJ
    Hershey, T
    Hartlein, JM
    Carl, JL
    Perlmutter, JS
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) : 590 - 601